Literature DB >> 14698192

The design and synthesis of novel inhibitors of NADH:ubiquinone oxidoreductase.

Stephen D Lindell1, Oswald Ort, Peter Lümmen, Robert Klein.   

Abstract

Potent new inhibitors of NADH:ubiquinone oxidoreductase (complex I) have been designed, with the help of molecular modelling, by hybridisation of known complex I inhibitors with inhibitors of cytochrome c oxidoreductase. The most interesting compound was the chromone 7 which was a selective inhibitor of complex I (IC(50) 15 nM) and showed acaricidal activity against spider mites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698192     DOI: 10.1016/j.bmcl.2003.10.022

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates.

Authors:  Ming Yu; Mary Guaraldi; Mikhail Kagan; Mahesh Mistry; Jennifer McDonald; Jody Bozek; Padmaja Yalamanchili; Megan Hayes; Michael Azure; Ajay Purohit; Heike Radeke; David S Casebier; Simon P Robinson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-21       Impact factor: 9.236

Review 2.  Mitochondrial-Targeted Molecular Imaging in Cardiac Disease.

Authors:  Jinhui Li; Jing Lu; You Zhou
Journal:  Biomed Res Int       Date:  2017-05-30       Impact factor: 3.411

Review 3.  Vitamin K2 in electron transport system: are enzymes involved in vitamin K2 biosynthesis promising drug targets?

Authors:  Michio Kurosu; Eeshwaraiah Begari
Journal:  Molecules       Date:  2010-03-10       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.